gout and tirzepatide risk change in uric acid and its association with weight reduction: post hoc analyses of the SURMOUNT-1 randomised placebo-controlled trial Tirzepatide Associated with Lower POAG, – In adults with obesity but

Can semaglutide worsen diabetic retinopathy or cause vision problems

This can result in weight loss, which, in situations where the extra weight poses a health risk, can be beneficial for ones overall health

Nevertheless, potential neuroprotective effects of triple receptor agonists can be expected from synergistic triggering a cascade of pathways relevant to metabolic homeostasis, oxidative stress, inflammation and neuronal survival

Purpose-built for physicians Study: Semaglutide slowed progression of CKD, cut cardiovascular events, mortality risk Key takeaways: FLOW trial results showed a 24% lower risk of kidney disease events and an 18% lower risk of cardiovascular events

Of these, four described co-existing melanin and haemosiderin deposits